What is Aptevo Therapeutics Inc's Market Cap?

Aptevo Therapeutics Inc's Market Cap is $3.4M, based on as-reported figures from SEC (XBRL) filings.

What is Aptevo Therapeutics Inc's Net Income (TTM)?

Aptevo Therapeutics Inc's Net Income (TTM) is -$26.4M, based on as-reported figures from SEC (XBRL) filings.

What is Aptevo Therapeutics Inc's EBITDA?

Aptevo Therapeutics Inc's EBITDA is -$26.7M, based on as-reported figures from SEC (XBRL) filings.

What is Aptevo Therapeutics Inc's Diluted EPS (TTM)?

Aptevo Therapeutics Inc's Diluted EPS (TTM) is -14.66, based on as-reported figures from SEC (XBRL) filings.

Aptevo Therapeutics Inc (APVO) Financial Statements

Aptevo Therapeutics Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG009RRZ8D1

XNAS · usd

1.88▲ 0.14 (8.05%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close1.74

Day's Range1.74 – 1.93

52-Week Range0.50 – 10.77

Volume167.8K

Avg Volume134.0K

Share Statistics

Shares Outstanding

Employees33

ExchangeXNAS

Listed2016-07-20

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Aptevo Therapeutics Inc (APVO)

What is Aptevo Therapeutics Inc's Market Cap?: Aptevo Therapeutics Inc's Market Cap is $3.4M, based on as-reported figures from SEC (XBRL) filings.
What is Aptevo Therapeutics Inc's Net Income (TTM)?: Aptevo Therapeutics Inc's Net Income (TTM) is -$26.4M, based on as-reported figures from SEC (XBRL) filings.
What is Aptevo Therapeutics Inc's EBITDA?: Aptevo Therapeutics Inc's EBITDA is -$26.7M, based on as-reported figures from SEC (XBRL) filings.
What is Aptevo Therapeutics Inc's Diluted EPS (TTM)?: Aptevo Therapeutics Inc's Diluted EPS (TTM) is -14.66, based on as-reported figures from SEC (XBRL) filings.